Bolt Biotherapeutics, Inc. (BOLT)
6.08
+0.17
(+2.88%)
USD |
NASDAQ |
Nov 13, 16:00
6.20
+0.12
(+1.97%)
Pre-Market: 19:59
Bolt Biotherapeutics Net Income (Quarterly) : -4.422M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -4.422M |
| June 30, 2026 | -7.72M |
| March 31, 2026 | -7.244M |
| December 31, 2025 | -6.631M |
| September 30, 2025 | -7.144M |
| June 30, 2025 | -8.561M |
| March 31, 2025 | -11.04M |
| December 31, 2024 | -15.94M |
| September 30, 2024 | -15.18M |
| June 30, 2024 | -21.20M |
| March 31, 2024 | -10.81M |
| December 31, 2023 | -17.90M |
| September 30, 2023 | -16.26M |
| June 30, 2023 | -18.06M |
| March 31, 2023 | -16.98M |
| Date | Value |
|---|---|
| December 31, 2022 | -20.00M |
| September 30, 2022 | -21.76M |
| June 30, 2022 | -22.66M |
| March 31, 2022 | -23.68M |
| December 31, 2021 | -27.16M |
| September 30, 2021 | -23.40M |
| June 30, 2021 | -23.58M |
| March 31, 2021 | -24.45M |
| December 31, 2020 | -31.04M |
| September 30, 2020 | -10.00M |
| June 30, 2020 | -11.06M |
| March 31, 2020 | -8.633M |
| December 31, 2019 | -9.362M |
| September 30, 2019 | -7.184M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Caribou Biosciences, Inc. | -26.61M |
| Oncolytics Biotech, Inc. | -9.705M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -28.46M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 4.422M |
| EPS Diluted (Quarterly) | -2.249 |
| Enterprise Value | 18.99M |
| Earnings Yield | -246.1% |
| Normalized Earnings Yield | -230.78 |